Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases
Clinical trial NCT07283315 · RECRUITING
Trial details
- NCT number
- NCT07283315
- Sponsor
- The Children's Hospital of Zhejiang University School of Medicine
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-03
- Primary completion
- 2028-12-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.